Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

被引：21

作者：

Inoue, Juliana ^{[1
]}

Silva, Miguel ^{[2
]}

Fofana, Bakary ^{[3
]}

Sanogo, Kassim ^{[3
]}

Martensson, Andreas ^{[1
]}

Sagara, Issaka ^{[3
]}

Bjorkman, Anders ^{[4
]}

Veiga, Maria Isabel ^{[2
]}

Ferreira, Pedro Eduardo ^{[2
]}

Djimde, Abdoulaye ^{[3
]}

Gil, Jose Pedro ^{[1
,4
,5
]}

机构：

[1] Uppsala Univ, Uppsala, Sweden

[2] Univ Minho, Braga, Portugal

[3] Univ Sci Tech & Technol Bamako, Bamako, Mali

[4] Karolinska Inst, Stockholm, Sweden

[5] Univ Lisbon, Lisbon, Portugal

来源：

EMERGING INFECTIOUS DISEASES | 2018年 / 24卷 / 08期

基金：

瑞典研究理事会;

关键词：

DIHYDROARTEMISININ-PIPERAQUINE; MALARIA; ASSOCIATION; EFFICACY; MALI;

D O I：

10.3201/eid2408.180370

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Dihydroartemisinin/piperaquine (DHA/PPQ) is increasingly deployed as an antimalaria drug in Africa. We report the detection in Mali of Plasmodium falciparum infections carrying plasmepsin 2 duplications (associated with piperaquine resistance) in 7/65 recurrent infections within 2 months after DHA/PPQ treatment. These findings raise concerns about the long-term efficacy of DHA/PPQ treatment in Africa.

引用

页码：1591 / 1593

页数：3

共 50 条

[1] Plasmodium falciparum ookinete expression of plasmepsin VII and plasmepsin X
Fengwu Li
Viengngeun Bounkeua
Kenneth Pettersen
Joseph M. Vinetz
Malaria Journal, 15
[2] Essentiality of Plasmodium falciparum plasmepsin V
Boonyalai, Nonlawat
Collins, Christine R.
Hackett, Fiona
Withers-Martinez, Chrislaine
Blackman, Michael J.
PLOS ONE, 2018, 13 (12):
[3] Plasmodium falciparum ookinete expression of plasmepsin VII and plasmepsin X
Li, Fengwu
Bounkeua, Viengngeun
Pettersen, Kenneth
Vinetz, Joseph M.
MALARIA JOURNAL, 2016, 15
[4] The structural stability of plasmepsin II from Plasmodium falciparum
Nezami, A
Freire, E
BIOPHYSICAL JOURNAL, 2000, 78 (01) : 295A - 295A
[5] Expression and characterisation of plasmepsin I from Plasmodium falciparum
Moon, RP
Tyas, L
Certa, U
Rupp, K
Bur, D
Jacquet, C
Matile, H
Loetscher, H
GrueningerLeitch, F
Kay, J
Dunn, BM
Berry, C
Ridley, RG
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 244 (02): : 552 - 560
[6] CHEMORESISTANCE OF PLASMODIUM-FALCIPARUM SPREADS TO WEST-AFRICA
LEBRASO, M
SOUBIRAND, G
LATASTE, P
LEBRAS, J
PRESSE MEDICALE, 1988, 17 (06): : 283 - 283
[7] Selective Inhibitors of Plasmepsin II of Plasmodium falciparum on the Basis of Pepstatin
Rumsh, L. D.
Mikhailova, A. G.
Mikhura, I. V.
Prudchenko, I. A.
Chikin, L. D.
Mikhaleva, I. I.
Kaliberda, E. N.
Dergousova, N. I.
Mel'nikov, E. E.
Formanovskii, A. A.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2008, 34 (06) : 660 - 667
[8] Selective inhibitors of plasmepsin II of Plasmodium falciparum on the basis of pepstatin
L. D. Rumsh
A. G. Mikhailova
I. V. Mikhura
I. A. Prudchenko
L. D. Chikin
I. I. Mikhaleva
E. N. Kaliberda
N. I. Dergousova
E. E. Mel’nikov
A. A. Formanovskii
Russian Journal of Bioorganic Chemistry, 2008, 34
[9] The zymogen of plasmepsin V from Plasmodium falciparum is enzymatically active
Xiao, Huogen
Bryksa, Brian C.
Bhaumik, Prasenjit
Gustchina, Alla
Kiso, Yoshiaki
Yao, Shao Q.
Wlodawer, Alexander
Yada, Rickey Y.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2014, 197 (1-2) : 56 - 63
[10] Yield improvement and enzymatic dissection of Plasmodium falciparum plasmepsin V
Loymunkong, Chaleampol
Sittikul, Pichamon
Songtawee, Napat
Wongpanya, Ratree
Boonyalai, Nonlawat
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2019, 231

← 1 2 3 4 5 →